Chiappella, A. Et Al. 2019. Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).

Chiappella, A., Witzig, T. E., Cocks, K., Greenwood, M., Williams, A., Scott, D. W., ... Gascoyne, R. D.(2019). Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America

Chiappella, Annalisa Et Al. "Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019

Chiappella, Annalisa Et Al. "Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019

Chiappella, A. Et Al. (2019) . "Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.

@conferencepaper{conferencepaper, author={Annalisa Chiappella Et Al. }, title={Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}